ADx is well on track to reach the goals of the grant.
ADx Neurosciences' battle against Parkinson's disease has been reinforced by the Michael J Fox Foundation. With the research grant acquired from the foundation, ADx will develop and validate new synuclein assays.
ADx has joined the CAVIA project for vascular imaging and fluid markers of amyloid deposition. We are happy to be part of this collaborative effort against dementia!